SEC Form 4 · accession 0001013762-15-000734
DelMar Pharmaceuticals, Inc. · DMPI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William J Garner
Director
Period of report
Jul 16, 2015
Accepted (ET)
Jul 17, 2015 · 10:25 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001498382
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 16, 2015 | P | 16,666 | $0.60 | A | 2,415,207 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant | $0.75 | Jul 16, 2015 | P | 16,666 | A | Jul 16, 2015 | Jul 16, 2020 | Common Stock | 16,666 | 16,666 | D |
Explanation of responses
- F15,000 shares are held by EGB Advisors, LLC, which is owned by Mr. Garner, and the remainder are held directly by Mr. Garner.